drugset / Trial / NCT07685600

Investigating the Effect of Itraconazole on the Pharmacokinetics of AZD4144 in Healthy Participants

NCT07685600

Phase 1 Not yet recruiting 32 enrolled AstraZeneca
RandomizedSequentialOpen-labelTreatment

Summary

The purpose of the study is to assess the pharmacokinetics (PK) of AZD4144 when administered alone and in combination with itraconazole in healthy participants.

Timeline

Start
2026-07-30
Primary completion
2026-10-28
Completion
2026-10-28

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD4144 Unknown Oral
Subject Itraconazole Small molecule Oral

Indications

No indication recorded.